Jon Imanol
Quintana
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoGlaxoSmithKline (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2020
-
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan–Conjugate Vaccine
Chemistry - A European Journal, Vol. 26, Núm. 31, pp. 7018-7025
-
Structure-Guided Design of a Group B Streptococcus Type III Synthetic Glycan-Conjugate Vaccine
Chemistry (Weinheim an der Bergstrasse, Germany), Vol. 26, Núm. 31, pp. 6944